September 2026
AACR's Annual Cancer Progress Report Highlights Advances in Cancer Research and Treatment
The AACR has published its 16th annual Cancer Progress Report, highlighting advancements in cancer research and treatment funded by U.S. federal agencies. While the report…
FDA Approves New Pill for Advanced Breast Cancer Guided by Blood Test
The FDA has approved a new daily pill for adults with advanced breast cancer, specifically for those whose tumors have evaded current treatments. This development…
FDA Approves New Treatment for Polycythemia Vera by Takeda Pharmaceuticals
The FDA has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) for treating adults with polycythemia vera who have not responded to current therapies. This approval marks a…
FDA Approves Blood Test for Alzheimer's Disease Evaluation
The U.S. FDA has approved the PrecivityAD2 blood test for adults over 40 to assess cognitive impairment related to Alzheimer's disease. This development involves the…
Peptide Supplements: The Marketing Surge Outpacing Scientific Evidence
The article discusses the rise of peptide supplements, highlighting the gap between marketing and scientific validation. While peptides like insulin and GLP-1 are FDA-approved, many…
FDA Approves First Oral Treatment for Dermatomyositis in Adults
The U.S. FDA has approved Lisraya (brepocitinib) as the first oral treatment for dermatomyositis in adults. This approval is significant as it represents advancements in…